Showing results (61-70 of 87) with videos related to
Sort By:
Pageof 9
Therapeutic Drug Monitoring|August 8, 2018
Longitudinal Study of Tacrolimus in Lymphocytes During the First Year After Kidney TransplantationRolf Anton Klaasen, Stein Bergan, Sara Bremer, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 1, 2009
Cyclosporine C2 levels have impact on incidence of rejection in de novo lung but not heart transplant recipients: the NOCTURNE studyMartin Iversen, Folke Nilsson, Jorma Sipponen, et al.Therapeutic Drug Monitoring|April 19, 2020
Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug InteractionsLaure Elens, Loralie J Langman, Dennis A Hesselink, et al.Clinical Pharmacology and Therapeutics|September 18, 2002
Pharmacokinetics of diltiazem and its metabolites in relation to CYP2D6 genotypeEspen Molden, Per Wiik Johansen, Grethe Helen Bøe, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 21, 2018
Effects of marine n-3 fatty acid supplementation in renal transplantation: A randomized controlled trialIvar A Eide, Finn P Reinholt, Trond Jenssen, et al.Atherosclerosis Plus|January 31, 2024
The atorvastatin metabolite pattern in muscle tissue and blood plasma is associated with statin muscle side effects in patients with coronary heart disease; An exploratory case-control studyTrine Lauritzen, John Munkhaugen, Stein Bergan, et al.Therapeutic Drug Monitoring|September 25, 2013
Simultaneous quantification of IMPDH activity and purine bases in lymphocytes using LC-MS/MS: assessment of biomarker responses to mycophenolic acidNils Tore Vethe, Ali Mohamad Ali, Pål Aarstrand Reine, et al.Clinical and Translational Science|July 12, 2020
Fasting Status and Circadian Variation Must be Considered When Performing AUC-based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant RecipientsMarte Theie Gustavsen, Karsten Midtvedt, Ida Robertsen, et al.Kidney International Reports|February 12, 2020
Measured GFR by Utilizing Population Pharmacokinetic Methods to Determine Iohexol ClearanceAnders Åsberg, Anna Bjerre, Runar Almaas, et al.British Journal of Clinical Pharmacology|January 12, 2020
Pharmacodynamic assessment of mycophenolic acid in resting and activated target cell population during the first year after renal transplantationRolf Anton Klaasen, Stein Bergan, Sara Bremer, et al.Pageof 9